Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
QuintilesIMS
Baxter
Citi
McKesson

Generated: March 20, 2019

DrugPatentWatch Database Preview

DEPO-TESTOSTERONE Drug Profile

« Back to Dashboard

When do Depo-testosterone patents expire, and what generic alternatives are available?

Depo-testosterone is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DEPO-TESTOSTERONE is testosterone cypionate. There are sixty-nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the testosterone cypionate profile page.

Drug patent expirations by year for DEPO-TESTOSTERONE
Pharmacology for DEPO-TESTOSTERONE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Synonyms for DEPO-TESTOSTERONE
(10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) 3-cyclopentylpropanoate
(17beta)-3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate
(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
053T944
17-(3-cyclopentyl-1-propionyl)-17beta-hydroxyandrost-4-en-3-one
17-(Cyclopentyl-1-oxopropoxy)androst-4-en-3-one, (17.beta.)-
17.beta.-Hydroxyandrost-4-en-3-one cyclopentylpropionate
17|A-Hydroxyandrost-4-en-3-one Cyclopentanepropionate
17|A-Hydroxyandrost-4-en-3-one Cyclopentylpropionate
17beta-Hydroxyandrost-4-en-3-one cyclopentylpropionate
3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate
3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate, (17.beta.)- #
3-oxoandrost-4-en-17beta-yl 3-cyclopentylpropanoate
58-20-8
AB0090519
AB01274709-01
AB2000228
AC1L1LLX
AC1L9B3P
AC1Q6P69
AKOS007930349
AKOS015895326
AKOS032955026
AN-41746
Andro-Cyp
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17b)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17beta)-
BRN 3174363
C-21939
C08156
CC-34816
CHEBI:9463
CHEMBL1201101
CT0176
D00957
Dep-Test
depAndro 100
depAndro 200
DEPO
Depo-Testadiol
Depo-testosterone (TN)
Depo-testosterone cyclopentylpropionate
Depo-Testosterone cypionate
Depotestosterone cypionate
Depovirin
DS-3318
Durandro
EINECS 200-368-4
HPFVBGJFAYZEBE-ZLQWOROUSA-N
I06-0701
Jectatest
LMST02020074
LS-148817
M0XW1UBI14
Malogen CYP
MolPort-003-959-637
MolPort-042-652-640
NSC 9157
NSC-9157
NSC9157
Pertestis
SC-22720
SCHEMBL40862
SCHEMBL5021654
T-Ionate-P.A
Testex Leo
Testodrin prolongatum
testosterone 17 beta-cyclopentanepropionate
testosterone 17 beta-cyclopentylpropionate
testosterone 17 beta-cypionate
Testosterone 17-beta-cypionate
Testosterone 17.beta.-cyclopentanepropionate
Testosterone 17.beta.-cyclopentylpropionate
Testosterone 17.beta.-cypionate
Testosterone 17|A-Cyclopentanepropionate
Testosterone 17|A-Cyclopentylpropionate
Testosterone 17|A-Cypionate
Testosterone 17beta-cyclopentanepropionate
Testosterone 17beta-cyclopentylpropionate
Testosterone 17beta-cypionate
Testosterone cyclopentanepropionate
Testosterone cyclopentylpropionate
TESTOSTERONE CYPIONATE
Testosterone cypionate (USP)
Testosterone cypionate [USAN]
Testosterone cypionate [USP]
Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard
Testosterone, cyclopentanepropionate
UNII-M0XW1UBI14
W-105407
ZINC4097468

US Patents and Regulatory Information for DEPO-TESTOSTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-002 Approved Prior to Jan 1, 1982 AO RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DEPO-TESTOSTERONE testosterone cypionate INJECTABLE;INJECTION 085635-003 Approved Prior to Jan 1, 1982 AO RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fuji
Accenture
Deloitte
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.